Corruption in health-care systems and its effect on cancer care in Africa

Mostert, Saskia; Njuguna, Festus; Olbara, Gilbert; Sindano, Solomon; Sitaresmi, Mei Neni; Supriyadi, Eddy; Kaspers, Gertjan J. L.

doi:10.1016/s1470-2045(15)00163-1

Cited by 64 publications

(130 citation statements)

References 35 publications

Supporting

Mentioning

126

Contrasting

Unclassified

Order By: Relevance

“…Without making any assumptions about any of the countries or hospitals in this review, clinicians and others should pay attention to the wider structure where, health care is delivered, as poorly focussed funding may not improve the situation or even exacerbate it if it is wasted on inappropriate interventions (such as equipment in the absence of skilled operators) or if it feeds corrupt practices. Thus, attention needs to be paid at all levels: governmental, hospital, healthcare provider and individual patient level intervention (Mostert et al., ). Explicit paediatric cancer strategies and funding may be important to prioritize and focus these aspects of care (Weaver, Yao, Renner, Harif, & Lam, ).…”

Section: Discussionmentioning

confidence: 99%

Treatment abandonment in children with cancer in Sub‐Saharan Africa: Systematic literature review and meta‐analysis

Mansell

Purssell

2017

Journal of Advanced Nursing

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Treatment abandonment in children with cancer in Sub‐Saharan Africa: Systematic literature review and meta‐analysis

Mansell

Purssell

2017

Journal of Advanced Nursing

View full text Add to dashboard Cite

show abstract

“…Chemotherapeutic-protocols from high income countries cannot be used in low income countries due to the lack of supportive care facilities and trained personnel. Less intensive, less toxic, and less expensive protocols are needed [7]. Equally, radiotherapy is highly inaccessible to most patients in Africa.…”

Section: Discussionmentioning

confidence: 99%

The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries

Lynch-Kelly

Singer

Williams

2017

International Journal of Breast Cancer

View full text Add to dashboard Cite

Objectives. The objectives of this study were to identify the randomised controlled trials in breast cancer occurring in low and middle income countries (LMICs) generally and within Sub-Saharan Africa specifically, to describe the current status and identify opportunities for further research in these areas. Materials and Methods. Data for this study were obtained from ClinicalTrials.gov. The search term “Breast Cancer Research” was used, and relevant information extracted and analysed. Results. 2414 trials were identified, of which 1099 were eligible for inclusion. 69 of these trials occurred in LMICs. Of the 52 LMICs globally, 30% were participating in breast cancer research. Of the 17 LMICs in Africa, 77% are situated in Sub-Saharan Africa; 23% were participating in breast cancer research, which accounted for 9% of total Sub-Saharan African studies. Conclusion. This study provides current evidence for the need for breast cancer research in LMICs globally and within Sub-Saharan Africa. Within LMIC regions where research is active, the type and numbers of studies are unevenly distributed. High quality research within such areas should be encouraged as the results may have both local and global applications, particularly in the provision of affordable health care.

show abstract

“…The consequences are devastating: low productivity, arrears, underutilized medical equipment, waiting lists, and extended hospitalizations. Patients are mainly taken care of by untrained, unsupervised junior staff …”

Section: Discussionmentioning

confidence: 99%